R Squared’s Neuronetics STIM Stock Holding History

R Squared’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-11,257	Closed	-$30.7K	–	706
2025 Q3	$30.7K	Sell	11,257 -3,766	-25%	-$13.4K	0.01%	519
2025 Q2	$52.4K	Buy	+15,023	New	+$59.3K	0.03%	390

Other funds holding STIM

MAM

Madryn Asset Management New York $36.9M AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return

FCM

FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

R Squared's STIM Position: Q4 2025 in Review

R Squared sold out of Neuronetics (STIM) in Q4 2025, closing a stake of 11,257 shares — an estimated $30.7K sold.

R Squared first reported a position in STIM in Q2 2025 and held it in 2 quarters. The position peaked at $52.4K in Q2 2025. 95 funds tracked by Wall St. Rank hold STIM as of Q4 2025.

R Squared reported no remaining Neuronetics position as of Q4 2025 after selling out during the quarter.
R Squared sold 11,257 Neuronetics shares in Q4 2025, an estimated $30.7K.
R Squared first reported a position in Neuronetics in Q2 2025 and held it in 2 quarters.
R Squared's Neuronetics position peaked at $52.4K in Q2 2025.
95 funds tracked by Wall St. Rank held Neuronetics as of Q4 2025.

Based on R Squared's 13F filing for Q4 2025, filed 30 Jan 2026.